Home
About
Services
Partners
Client Portfolio
News
Contact
Exclusive: Kenya’s Safaricom taking M-Pesa to Ethiopia, sources say
July 17, 2018
UnitedHealth second quarter medical costs miss estimates, shares slide
July 17, 2018
0
Johnson & Johnson profit beat fueled by strength in pharma business
Published by
Muller&Green
at
July 17, 2018
Categories
RSS
Tags
Johnson & Johnson topped analysts’ estimates for quarterly profit and revenue on Tuesday, as strong demand for cancer drugs Zytiga and Darzalex more than made up for declining sales of blockbuster treatment Remicade.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more